James H O'Keefe

Summary

Affiliation: Mid America Heart Institute
Country: USA

Publications

  1. ncbi Atorvastatin reduces remnant lipoproteins and small, dense low-density lipoproteins regardless of the baseline lipid pattern
    James H O'Keefe
    Mid America Heart Institute, St Luke s Hospital, 4401 Wornall Road, Suite 2000, Kansas City, MO 64111
    Prev Cardiol 7:154-60. 2004
  2. ncbi Testing the performance of the ENRICHD Social Support Instrument in cardiac patients
    Joseph Vaglio
    Mid America Heart Institute at St Lukes Hospital, Kansas City, MO, USA
    Health Qual Life Outcomes 2:24. 2004
  3. ncbi Dietary strategies for the prevention & treatment of metabolic syndrome
    James H O'Keefe
    Mid America Heart Institute University of Missouri Kansas City, USA
    Mo Med 107:406-9. 2010
  4. ncbi Effect of chronic right ventricular apical pacing on left ventricular function
    James H O'Keefe
    Mid America Heart Institute, Kansas City, Missouri 64111, USA
    Am J Cardiol 95:771-3. 2005
  5. ncbi Organic fitness: physical activity consistent with our hunter-gatherer heritage
    James H O'Keefe
    Mid America Heart Institute University of Missouri Kansas City, MO, USA
    Phys Sportsmed 38:11-8. 2010
  6. ncbi The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin)
    James H O'Keefe
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, MO 64111, USA
    Postgrad Med 121:113-8. 2009
  7. ncbi Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer
    James H O'Keefe
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, MO 64111, USA
    Mayo Clin Proc 79:101-8. 2004
  8. ncbi Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health
    James H O'Keefe
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, Missouri, USA
    J Am Coll Cardiol 51:249-55. 2008
  9. ncbi Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal
    James H O'Keefe
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 43:2142-6. 2004
  10. ncbi Achieving hunter-gatherer fitness in the 21(st) century: back to the future
    James H O'Keefe
    Mid America Heart Institute University of Missouri Kansas City, Kansas City, MO 64111, USA
    Am J Med 123:1082-6. 2010

Collaborators

Detail Information

Publications98

  1. ncbi Atorvastatin reduces remnant lipoproteins and small, dense low-density lipoproteins regardless of the baseline lipid pattern
    James H O'Keefe
    Mid America Heart Institute, St Luke s Hospital, 4401 Wornall Road, Suite 2000, Kansas City, MO 64111
    Prev Cardiol 7:154-60. 2004
    ..Increased attention should be paid to absolute concentrations of LDL subfraction cholesterol, which may be a more sensitive indicator of coronary heart disease risk than total LDL or an LDL pattern...
  2. ncbi Testing the performance of the ENRICHD Social Support Instrument in cardiac patients
    Joseph Vaglio
    Mid America Heart Institute at St Lukes Hospital, Kansas City, MO, USA
    Health Qual Life Outcomes 2:24. 2004
    ..Validity and reliability of the ESSI, however, has not been formally tested in patients undergoing percutaneous coronary intervention (PCI)...
  3. ncbi Dietary strategies for the prevention & treatment of metabolic syndrome
    James H O'Keefe
    Mid America Heart Institute University of Missouri Kansas City, USA
    Mo Med 107:406-9. 2010
    ....
  4. ncbi Effect of chronic right ventricular apical pacing on left ventricular function
    James H O'Keefe
    Mid America Heart Institute, Kansas City, Missouri 64111, USA
    Am J Cardiol 95:771-3. 2005
    ....
  5. ncbi Organic fitness: physical activity consistent with our hunter-gatherer heritage
    James H O'Keefe
    Mid America Heart Institute University of Missouri Kansas City, MO, USA
    Phys Sportsmed 38:11-8. 2010
    ..In a sedentary individual, this type of daily physical activity should help confer the robust vigorous health that enabled our ancestors to survive and thrive as hunter-gatherers in the wild...
  6. ncbi The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin)
    James H O'Keefe
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, MO 64111, USA
    Postgrad Med 121:113-8. 2009
    ..Simvastatin, at the 80-mg daily dose, is more toxic to muscles and liver than other statins at their highest dose, and thus should be used with caution...
  7. ncbi Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer
    James H O'Keefe
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, MO 64111, USA
    Mayo Clin Proc 79:101-8. 2004
    ..This review outlines the essence of our hunter-gatherer genetic legacy and suggests practical steps to re-align our modern milieu with our ancient genome in an effort to improve cardiovascular health...
  8. ncbi Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health
    James H O'Keefe
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, Missouri, USA
    J Am Coll Cardiol 51:249-55. 2008
    ..This anti-inflammatory diet should be considered for the primary and secondary prevention of coronary artery disease and diabetes...
  9. ncbi Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal
    James H O'Keefe
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 43:2142-6. 2004
    ..No major safety concerns have surfaced in studies that lowered LDL to this range of 50 to 70 mg/dl. The current guidelines setting the target LDL at 100 to 115 mg/dl may lead to substantial undertreatment in high-risk individuals...
  10. ncbi Achieving hunter-gatherer fitness in the 21(st) century: back to the future
    James H O'Keefe
    Mid America Heart Institute University of Missouri Kansas City, Kansas City, MO 64111, USA
    Am J Med 123:1082-6. 2010
    ..Suggestions for exercise mode, duration, intensity, and frequency are outlined with a focus on realigning our daily physical activities with the archetype that is encoded within our genome...
  11. ncbi Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach
    James H O'Keefe
    Mid America Heart Institute and University of Missouri Kansas City, Missouri, USA
    Mayo Clin Proc 84:741-57. 2009
    ..Specific CV risk factors and optimal therapies for primary and secondary prevention are discussed...
  12. ncbi Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor
    James H O'Keefe
    University of Missouri Kansas City, Kansas City, Missouri, USA
    Am J Cardiol 100:899-904. 2007
    ..Diet, exercise, and various pharmacologic agents can improve postprandial dysmetabolism. Using these strategies may help improve the prognosis for patients with diabetes mellitus and/or coronary heart disease...
  13. ncbi Alcohol and cardiovascular health: the razor-sharp double-edged sword
    James H O'Keefe
    Mid America Heart Institute, University of Missouri, Kansas City, Missouri, USA
    J Am Coll Cardiol 50:1009-14. 2007
    ..Alcohol should not be universally prescribed for health enhancement to nondrinking individuals owing to the lack of randomized outcome data and the potential for problem drinking...
  14. ncbi Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS
    J H O'Keefe
    University of Missouri Kansas City School of Medicine, Mid America Heart Institute, St Luke s Hospital, Kansas City, MO 64111, USA
    Diabetes Obes Metab 10:492-7. 2008
    ..We retrospectively evaluated the effect of eplerenone vs. placebo in a subset of 1483 diabetic patients with LVSD and signs of CHF following AMI...
  15. ncbi The renin-angiotensin-aldosterone system as a target in coronary disease
    James H O'Keefe
    Cardiovascular Consultants, Mid America Heart Institute, Suite 2000, 4320 Wornall Road, Kansas City, MO 64111, USA
    Curr Atheroscler Rep 5:124-30. 2003
    ..Aldosterone receptor blockers appear to provide additive benefit when used in conjunction with either an ACE inhibitor or an angiotensin receptor blocker...
  16. ncbi Exercise like a hunter-gatherer: a prescription for organic physical fitness
    James H O'Keefe
    Mid America Heart and Vascular Institute University of Missouri, Kansas City, MO 64108, USA
    Prog Cardiovasc Dis 53:471-9. 2011
    ..In a typical inactive person, this type of daily physical activity will optimize gene expression and help to confer the robust health that was enjoyed by hunter-gatherers in the wild...
  17. ncbi Cardiometabolic abnormalities in current National Football League players
    Michael A Selden
    University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    Am J Cardiol 103:969-71. 2009
    ..004; 100% vs 32%, p <0.001, and 95% vs 36%, p <0.001 respectively). In conclusion, cardiometabolic syndrome and its individual components were noted in current NFL players, particularly linemen...
  18. ncbi Elevated alanine aminotransferase in current national football league players: correlation with cardiometabolic syndrome markers, obesity, and insulin resistance
    Michael A Selden
    University of Missouri Kansas City School of Medicine, Saint Luke s Hospital of Kansas City, and Mid America Heart Institute, Kansas City, MO, USA
    South Med J 102:1003-6. 2009
    ....
  19. ncbi Clinical utility of coronary calcium scoring after nonischemic myocardial perfusion imaging
    Randall C Thompson
    Cardiovascular Consultants PC, 4330 Wornall Road, Suite 2000, Kansas City, MO 64111, USA
    J Nucl Cardiol 12:392-400. 2005
    ..Coronary artery calcium (CAC) scoring is increasingly being used after myocardial perfusion imaging (MPI) to detect preclinical coronary artery disease (CAD). However, there are few data to support this approach...
  20. ncbi Comparison of outcomes among moderate alcohol drinkers before acute myocardial infarction to effect of continued versus discontinuing alcohol intake after the infarct
    Maia D Carter
    Mid America Heart Institute of Saint Luke s Hospital, Kansas City, Missouri, USA
    Am J Cardiol 105:1651-4. 2010
    ..In conclusion, these data suggest that there are no adverse effects for moderate drinkers to continue consuming alcohol and that they may have better physical functioning compared to those who quit drinking after an AMI...
  21. ncbi Dobutamine-induced chest pain does not predict ischemic findings on myocardial perfusion imaging
    John H Lee
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, Missouri, USA
    J Nucl Cardiol 15:526-9. 2008
    ..The purpose of this study is to explore the correlation between dobutamine-induced chest pain and evidence of ischemia on myocardial perfusion imaging (MPI)...
  22. ncbi Comparison of cardiovascular and metabolic risk factors in professional baseball players versus professional football players
    John H Helzberg
    Saint Luke s Hospital of Kansas City, University of Missouri Kansas City School of Medicine, Missouri, USA
    Am J Cardiol 106:664-7. 2010
    ....
  23. ncbi Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction
    Adam C Salisbury
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Am J Cardiol 109:13-8. 2012
    ....
  24. ncbi Predictors of omega-3 index in patients with acute myocardial infarction
    Adam C Salisbury
    Department of Cardiovascular Diseases, Saint Luke s Mid America Heart and Vascular Institute, Kansas City, MO 64111, USA
    Mayo Clin Proc 86:626-32. 2011
    ....
  25. ncbi Review article: eplerenone: an underused medication?
    Mohammad Abuannadi
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, MO, USA
    J Cardiovasc Pharmacol Ther 15:318-25. 2010
    ..In conclusion, eplerenone is a medication that offers the cardiovascular therapeutic and prognostic benefits of aldosterone antagonism but with fewer side effects compared to spironolactone...
  26. ncbi Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin
    Kevin A Bybee
    Saint Luke s Mid America Heart Institute and University of Missouri Kansas City, Kansas City, MO, USA
    Curr Med Res Opin 24:1217-29. 2008
    ....
  27. ncbi Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus
    James H O'Keefe
    Mid America Heart and Vascular Institute and University of Missouri Kansas City, Kansas City, MO, USA
    Mayo Clin Proc 86:128-38. 2011
    ..We conducted a systematic review of English articles using MEDLINE and the Cochrane Controlled Trials Register (1970-2010) using the following search terms: cardiovascular disease, randomized trials, hypoglycemia, and insulin resistance...
  28. ncbi Potential adverse cardiovascular effects from excessive endurance exercise
    James H O'Keefe
    Mid America Heart Institute of Saint Luke s Hospital of Kansas City, MO, USA
    Mayo Clin Proc 87:587-95. 2012
    ....
  29. ncbi Erectile dysfunction as a coronary artery disease risk equivalent
    John H Lee
    Mid America Heart Institute, Kansas City, MO, USA
    J Nucl Cardiol 15:800-3. 2008
    ....
  30. ncbi Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation
    Hussam Abuissa
    University of Missouri, Kansas City, Missouri, USA
    Clin Cardiol 32:544-8. 2009
    ..Recent studies have demonstrated that statins may possess antiarrhythmic properties in addition to their lipid-lowering effects...
  31. ncbi Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials
    Hussam Abuissa
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 46:821-6. 2005
    ..We sought to investigate the role of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in preventing the new onset of type 2 diabetes mellitus...
  32. ncbi Prevalence of vitamin D deficiency in patients with acute myocardial infarction
    John H Lee
    Mid America Heart and Vascular Institute and University of Missouri Kansas City, Kansas City, MO, USA
    Am J Cardiol 107:1636-8. 2011
    ..2 vs 29.0 kg/m(2), p = 0.025) were also observed in 25(OH)D-deficient subjects. In conclusion, vitamin D deficiency is present in almost all patients with acute myocardial infarction in a multicenter United States cohort...
  33. ncbi Omega-3 fatty acids: cardiovascular benefits, sources and sustainability
    John H Lee
    Mid America Heart Institute and University of Missouri Kansas City, 64111, USA
    Nat Rev Cardiol 6:753-8. 2009
    ..Sustainable sources of omega-3 fatty acids will need to be identified if long-term cardiovascular risk reduction is to be achieved at the population level...
  34. ncbi Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
    John H Lee
    Mid America Heart Institute and University of Missouri, Kansas City, Missouri, USA
    J Am Coll Cardiol 52:1949-56. 2008
    ..In the meanwhile, monitoring serum 25-hydroxyvitamin D levels and correction of vitamin D deficiency is indicated for optimization of musculoskeletal and general health...
  35. ncbi Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging
    Kevin A Bybee
    University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    J Nucl Cardiol 17:188-96. 2010
    ..One advantage of MPI with a hybrid CT device is the ability to obtain same-setting measurement of the coronary artery calcium score (CACS)...
  36. ncbi Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, USA
    BMC Res Notes 4:542. 2011
    ..abstract:..
  37. ncbi Omega-3 fatty acids for cardioprotection
    John H Lee
    Mid America Heart Institute and University of Missouri Kansas City, 4330 Wornall Road, Kansas City, MO 64111, USA
    Mayo Clin Proc 83:324-32. 2008
    ..Blood DHA and EPA levels could one day be used to identify patients with deficient levels and to individualize therapeutic recommendations...
  38. ncbi Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension
    Firas J Al Badarin
    Mid America Heart and Vascular Institute, Saint Luke s Hospital and University of Missouri Kansas City, Kansas City, Missouri, USA
    Am J Cardiol 107:1178-84. 2011
    ....
  39. ncbi Interscan variability of coronary artery calcium quantification using an electrocardiographically pulsed spiral computed tomographic protocol
    Kevin W Moser
    Cardiovascular Imaging Technologies, L L C, Kansas City, Missouri, USA
    Am J Cardiol 93:1153-5. 2004
    ..For Agatston scores <10, the interscan variability of such a protocol was significantly lower than that for a sequential acquisition protocol. At higher Agatston scores, the 2 protocols had similar variability characteristics...
  40. ncbi Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias
    Hussam Abuissa
    University of Missouri, Kansas City, Missouri, USA
    Clin Cardiol 32:549-52. 2009
    ..Recent studies have demonstrated that statins may possess anti-arrhythmic properties in addition to their lipid-lowering effects...
  41. ncbi Strategies to prevent type 2 diabetes
    Hussam Abuissa
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, MO 64111, USA
    Curr Med Res Opin 21:1107-14. 2005
    ....
  42. ncbi Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus
    Harshal R Patil
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    Am J Cardiol 110:826-33. 2012
    ..40 (0.18 to 0.88, p = 0.02). In conclusion, this meta-analysis provides evidence that DPP4 inhibitors are safe from a CV standpoint and may possibly decrease risk of adverse CV events...
  43. ncbi Assessment of and physician response to glycemic control in diabetic patients presenting with an acute coronary syndrome
    Darcy L Green Conaway
    Mid America Heart Institute of Saint Luke s Hospital, Kansas City, MO 64111, USA
    Am Heart J 152:1022-7. 2006
    ..The frequency with which physicians assess diabetic patients' glycemic control during an ACS hospitalization is not known and may represent an opportunity for quality improvement...
  44. ncbi Review of cardiometabolic risk factors among current professional football and professional baseball players
    John H Helzberg
    Saint Luke s Hospital of Kansas City, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    Phys Sportsmed 38:77-83. 2010
    ..However, caution should be used in the interpretation of increased cardiovascular disease risk, as it does not necessarily translate into early increased mortality...
  45. ncbi Cardiac physical diagnosis in the digital age: an important but increasingly neglected skill (from stethoscopes to microchips)
    Robert D Conn
    Mid America Heart Institute and University of Missouri Kansas City, Kansas City, Missouri, USA
    Am J Cardiol 104:590-5. 2009
    ..In conclusion, even in the digital age, the physical examination remains uniquely relevant to patient care, particularly when focused on the physiologic status of the cardiac patent...
  46. ncbi Cuppa joe: friend or foe? Effects of chronic coffee consumption on cardiovascular and brain health
    Harshal Patil
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, USA
    Mo Med 108:431-8. 2011
    ....
  47. ncbi A longer course of varenicline therapy improves smoking cessation rates
    John H Lee
    Mid America Heart Institute and University of Missouri Kansas City, USA
    Prev Cardiol 11:210-4. 2008
    ..In conclusion, a meta-analysis of randomized controlled trials suggests that longer duration of varenicline therapy improves long-term abstinence rates...
  48. ncbi Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome
    Darcy Green Conaway
    Mid America Heart Institute of Saint Luke s Hospital, University of Missouri, Kansas City, Missouri, USA
    Am J Cardiol 96:363-5. 2005
    ..A total of 57% of patients who had acute coronary syndrome had abnormal glucose metabolism; approximately 66% of those who met criteria for new diabetes were not diagnosed or treated as such by the physicians who managed them...
  49. ncbi Clinical factors associated with left ventricular ejection fraction disparity in patients with left ventricular dysfunction undergoing multimodality imaging
    Adnan Khalid
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri, USA
    Mo Med 109:489-92. 2012
    ..These clinical variables included atrial fibrillation, left ventricular hypertrophy, severe mitral regurgitation and paced rhythm...
  50. ncbi Improving in-hospital mortality in the setting of an increasing risk profile among patients undergoing catheter-based reperfusion for an acute myocardial infarction without cardiogenic shock
    Steven P Marso
    Mid America Heart Institute, St Luke s Hospital, Kansas City, Missouri 64111, USA
    J Invasive Cardiol 15:711-6. 2003
    ..89; 95% CI 0.8 0.98; p = 0.017). Despite the changing risk profile, the short-term mortality continues to improve for patients undergoing AMI PCI...
  51. ncbi Neckties for physicians: Yes? No? Maybe?
    Mohammad Abuannadi
    Mid America Heart Institute University of Missouri Kansas City, USA
    Mo Med 107:366-7. 2010
    ..Both pathogenic and non-pathogenic bacteria commonly colonize neckties and avoiding neckties is a simple measure that may prove helpful in our fight against nosocomial infections...
  52. ncbi Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein
    Loren Cordain
    Mid America Heart Institute, Kansas City, Missouri, USA
    Am J Cardiol 98:135-9. 2006
    ..Therefore, intensive LDL cholesterol reduction to levels of 30 to 70 mg/dl should be pursued in subjects with or at high risk for coronary artery disease...
  53. ncbi Heart failure in the diabetic patient
    David S H Bell
    University of Alabama Medical School, Birmingham, AL, USA
    Cardiol Clin 25:523-38; vi. 2007
    ..Also reviewed are the therapies that are available for the treatment of diabetic HF and whether intensifying the use of these therapies might improve the worsened clinical outcomes for the patient who has diabetes...
  54. ncbi Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial
    Jackson T Wright
    Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
    J Clin Hypertens (Greenwich) 9:842-9. 2007
    ..The use of carvedilol compared with metoprolol did not effect glycemic control...
  55. ncbi Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?
    David S H Bell
    Southside Endocrinology, Birmingham, Alabama 35205, USA
    Endocr Pract 14:112-24. 2008
    ..To investigate the association of postprandial dysmetabolism, ie, hyperglycemia, and hyperlipidemia with myocardial disease in diabetic, glucose-intolerant, and glucose-tolerant patients...
  56. ncbi The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis
    David S H Bell
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama Medical School, Birmingham, Alabama 35294, USA
    Curr Med Res Opin 22:287-96. 2006
    ..However, some trial results indicate that carvedilol, which blocks beta1-, beta2-, and alpha1-receptors and is a potent antioxidant, may produce at least comparable effects in both patient groups...
  57. ncbi Statin neuropathy masquerading as diabetic autoimmune polyneuropathy
    Tom Brooks Vaughan
    Diabetes Care 28:2082. 2005
  58. ncbi Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial
    George L Bakris
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Ill, USA
    JAMA 292:2227-36. 2004
    ..The effects of the 2 beta-blockers on clinical outcomes need to be compared in long-term clinical trials...
  59. ncbi A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approaches
    David S H Bell
    School of Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA
    Treat Endocrinol 3:67-76. 2004
    ..Furthermore, early use of an insulin-sensitizing agent either alone or incombination is expected to improve both acute and long-term outcomes in patients with type 2 diabetes...
  60. ncbi Advantages of a third-generation beta-blocker in patients with diabetes mellitus
    David S H Bell
    Department of Medicine, University of Alabama at Birmingham Medical School, Birmingham, Alabama 35294, USA
    Am J Cardiol 93:49B-52B. 2004
    ..However, carvedilol, a nonselective beta-blocker with vasodilating and insulin-sensitizing properties, can largely circumvent these problems and is the ideal beta-blocker for the patient with diabetes...
  61. ncbi Lipoprotein effects of different thiazolidinediones in clinical practice
    Fernando Ovalle
    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham School of, Medicine, Birmingham, Alabama, USA
    Endocr Pract 8:406-10. 2002
    ..Overall, the changes in lipoprotein profile induced by rosiglitazone therapy seem to have less atherogenic potential than those resulting from the use of troglitazone...
  62. ncbi Advances in diabetes for the millennium: the heart and diabetes
    David S H Bell
    University of Alabama School of Medicine, Birmingham, USA
    MedGenMed 6:7. 2004
    ..Antidiabetic agents that target insulin resistance may be more cardioprotective than those that primarily augment insulin secretion...
  63. ncbi Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes
    George L Bakris
    Rush University Medical Center, Chicago, IL 60612, USA
    Hypertension 46:1309-15. 2005
    ..These differences cannot be explained by effects on blood pressure or alpha1-antagonism but may relate to antioxidant properties of carvedilol...
  64. ncbi Treatment of heart failure in patients with diabetes: clinical update
    David S H Bell
    Division of Endocrinology and Metabolism, The University of Alabama at Birmingham, School of Medicine, USA
    Ethn Dis 12:S1-12-8. 2002
    ..There is evidence that glycemic control is also important in improving clinical outcomes. The adverse effects of beta-blockade on carbohydrate and lipid metabolism and vasoconstriction may be circumvented by the use of carvedilol...
  65. ncbi Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade
    David S H Bell
    Division of Endocrinology, Department of Medicine, University of Alabama Medical School, Birmingham, AL 35294, USA
    Curr Med Res Opin 21:1191-200. 2005
    ..Despite this benefit of beta-blockers, physicians have been reluctant to use them in patients with diabetes, in whom they are even more effective, because of the negative effects on carbohydrate and lipid metabolism...
  66. ncbi Thiazolidinedione-associated congestive heart failure and pulmonary edema
    David S H Bell
    Mayo Clin Proc 79:572; author reply 575-7. 2004
  67. ncbi Insulin as initial therapy for type 2 diabetes is not in the patient's best interest
    David S H Bell
    University of Alabama School of Medicine, Birmingham, Alabama 35294, USA
    Endocr Pract 10:208-12. 2004
  68. ncbi Triple oral therapy for type 2 diabetes
    David S H Bell
    Diabetes Res Clin Pract 78:313-5. 2007
  69. ncbi Type 2 diabetes mellitus: what is the optimal treatment regimen?
    David S H Bell
    Department of Medicine, University of Alabama at Birmingham Medical School, Birmingham, Alabama 35294, USA
    Am J Med 116:23S-29S. 2004
    ....
  70. ncbi Chronic complications of diabetes
    David S H Bell
    Department of Medicine, University of Alabama at Birmingham, 35294, USA
    South Med J 95:30-4. 2002
  71. ncbi Long-term efficacy of triple oral therapy for type 2 diabetes mellitus
    David S H Bell
    Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294, USA
    Endocr Pract 8:271-5. 2002
    ....
  72. ncbi Beneficial effects resulting from thiazolidinediones for treatment of type 2 diabetes mellitus
    David S H Bell
    University of Alabama at Birmingham, School of Medicine, Department of Medicine, Birmingham, USA
    Postgrad Med . 2003
    ..TZDs can be used safely in renally impaired patients with diabetes, and hepatotoxicity has not been a problem with second-generation TZDs, making these agents both safe and effective in the treatment of type 2 diabetes...
  73. ncbi Constructing an algorithm for managing type 2 diabetes. Focus on role of the thiazolidinediones
    Kathleen L Wyne
    Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 8857, USA
    Postgrad Med . 2003
    ..Notably, decreasing insulin resistance also may reduce the incidence of adverse atherosclerotic consequences...
  74. ncbi Heart failure: the frequent, forgotten, and often fatal complication of diabetes
    David S H Bell
    Department of Medicine, University of Alabama at Birmingham, USA
    Diabetes Care 26:2433-41. 2003
    ..Prophylactic utilization of ACE inhibitors and beta-blockers to avoid, rather than await, the need to treat HF should be considered in high-risk diabetic patients...
  75. ncbi Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetes
    David S H Bell
    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294, USA
    Endocr Pract 9:98-101. 2003
  76. ncbi Unilateral edema due to a thiazolidinedione
    David S H Bell
    Diabetes Care 26:2700. 2003
  77. ncbi Diabetic cardiomyopathy
    David S H Bell
    Diabetes Care 26:2949-51. 2003
  78. ncbi Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy
    Eric S Albright
    Diabetes Care 27:632-3. 2004
  79. ncbi C-reactive protein and glycemic control in adults with diabetes: response to King et al
    David S H Bell
    Diabetes Care 27:637; author reply 637-8. 2004
  80. ncbi Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes
    Fernando Ovalle
    Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA
    Diabetes Care 27:2585-9. 2004
    ..This improvement was independent of the correction of glucotoxicity...
  81. ncbi Current status of diabetes treatment
    David S H Bell
    Department of Medicine, University of Alabama at Birmingham, 35294, USA
    South Med J 95:24-9. 2002
  82. ncbi Body weight changes with beta-blocker use: results from GEMINI
    Franz H Messerli
    St Luke s Roosevelt Hospital Center, New York City, NY 10019, USA
    Am J Med 120:610-5. 2007
    ....
  83. ncbi Insulin resistance and thrombogenesis: recent insights and therapeutic implications
    Hisham A Baalbaki
    Heart Health Center PC, Florence, Alabama 35631, USA
    Endocr Pract 13:679-86. 2007
    ..To review the relationship between insulin resistance and thrombogenesis, especially in the context of obesity, diabetes, and cardiovascular disease, and to discuss therapeutic implications...
  84. ncbi The multifaceted associations of hepatobiliary disease and diabetes
    David S H Bell
    Southside Endocrinology, Birmingham, Alabama 35205, USA
    Endocr Pract 13:300-12. 2007
    ..To investigate the association of diabetes and hepatobiliary disease...
  85. ncbi Treatment of infertility in the polycystic ovary syndrome
    David S H Bell
    N Engl J Med 356:1999-2000; author reply 2000-1. 2007
  86. ncbi The decrease in microalbuminuria with carvedilol therapy is not enhanced by concurrent use of a statin
    David S H Bell
    Endocr Pract 13:808-9. 2007
  87. ncbi Hyperinsulinemic hypoglycemia precipitated by weight loss
    Maria S Prelipcean
    University of Alabama Medical School, Birmingham, AL, USA
    South Med J 98:726-8. 2005
    ..Voluntary weight loss, by lowering insulin resistance, accelerates the time to clinical presentation of an asymptomatic insulinoma...
  88. ncbi Treatment of type 2 diabetes. Use of fixed-dose oral combinations
    David S H Bell
    University of Alabama at Birmingham School of Medicine, USA
    Postgrad Med 119:8-14. 2006
  89. ncbi Anemia and the role of erythropoietin in diabetes
    Janet B McGill
    Washington University School of Medicine, St. Louis, MO, USA
    J Diabetes Complications 20:262-72. 2006
    ..Promptly diagnosing and treating anemia in patients with diabetes may result in an improved quality of life and decreased morbidity and mortality...
  90. ncbi The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes
    David S H Bell
    Diabetes Care 29:483; author reply 483-4. 2006
  91. ncbi Letter by Bell and O'keefe regarding article, "Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease"
    David S H Bell
    Circulation 118:e156; author reply e157. 2008
  92. ncbi Do sulfonylurea drugs increase the risk of cardiac events?
    David S H Bell
    University of Alabama at Birmingham, Birmingham, Ala, USA
    CMAJ 174:185-6. 2006
  93. ncbi A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et al
    David S H Bell
    Diabetes Care 28:2983-4; author reply 2985-6. 2005
  94. ncbi Maximally utilizing the available agents for the treatment of type 2 diabetes
    David S H Bell
    Clin Med Res 1:173-4. 2003
  95. ncbi The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial
    George L Bakris
    Rush Hypertension Center, Rush Medical Center, Suite 470, 1700 W Van Buren, Chicago, IL 60612, USA
    J Diabetes Complications 19:74-9. 2005
    ..The GEMINI trial, therefore, is the first large randomized trial to assess whether utilizing a third-generation beta-blocker yields a favorable metabolic profile in the patient with Type 2 diabetes and hypertension...
  96. ncbi Stockpiling of ovarian follicles and the response to rosiglitazone
    Tom Brooks Vaughan
    Diabetes Care 28:2333-4. 2005
  97. ncbi Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy
    David S H Bell
    University of Alabama Medical School, Faculty Office Towers, 510 20th Street South, Room 702, Birmingham, AL 35294, USA
    Clin Ther 26:1714-27. 2004
    ....
  98. ncbi Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
    David S H Bell
    University of Alabama at Birmingham Medical School, Birmingham, Alabama, USA
    Drugs 67:1813-27. 2007
    ..In addition, maximisation of glycaemic control will result in prevention, delay of onset or amelioration of both the microvascular and perhaps the macrovascular complications of diabetes...